BridgeMD
New treatment option for Cardiovascular Risk Factor
Official title Abertay Tea for Cardiovascular Health During Menopause
ClinicalTrials.gov ID: NCT07070635
What this study is testing
- What it's testing
- The regular consumption of seaweed, as observed in Japan, is associated to a reduced cardiovascular risk and prolonged life expectancy. Interventional studies have shown that brown seaweed consumption can reduce blood pressure, improve glycaemic control and lipoprotein profiles, although this varies with population, dose, duration and the type of seaweed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 74, women only. Healthy volunteers may be eligible.
You may be able to join if
- Postmenopausal status: no menstrual period over the last 12 months
- Regular tea drinkers (at least once a week), willingness to consume 3 cups of English breakfast tea per day for 8 weeks
- BMI between 18.5 and 39.99 kg/m2
You likely can't join if
- Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke, dyslipidemia), diabetes (or fasting glucose ≥ 6.1 mmol/L), kidney...
- Recent history of cancer (\<1y)
- History indicative of a congenital or acquired platelet or haemostatic defect.
- Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption.
- Recent use of hypolipidaemic, antiplatelet or antithrombotic medications
- Impairment of thyroid function
See the full eligibility criteria
- Postmenopausal status: no menstrual period over the last 12 months
- Regular tea drinkers (at least once a week), willingness to consume 3 cups of English breakfast tea per day for 8 weeks
- BMI between 18.5 and 39.99 kg/m2
- Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke, dyslipidemia), diabetes (or fasting glucose ≥ 6.1 mmol/L), kidney, liver or bowel disease.
- Recent history of cancer (\<1y)
- History indicative of a congenital or acquired platelet or haemostatic defect.
- Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption.
- Recent use of hypolipidaemic, antiplatelet or antithrombotic medications
- Impairment of thyroid function
- Current smokers or vapers
- Current self-reported weekly alcohol intake exceeding 14 units
- Current or recent use of hormone replacement therapy (\<3 months)
- Recent participation in another clinical trial (\<3 months)
- Allergy or intolerance to crustaceans or iodine
The study team makes the final eligibility decision.
Where it's taking place
- Dundee, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 74 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dundee, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.